1. Home
  2. SOBR vs CDT Comparison

SOBR vs CDT Comparison

Compare SOBR & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOBR Safe Inc.

SOBR

SOBR Safe Inc.

HOLD

Current Price

$0.59

Market Cap

2.4M

ML Signal

HOLD

Logo Conduit Pharmaceuticals Inc.

CDT

Conduit Pharmaceuticals Inc.

HOLD

Current Price

$2.92

Market Cap

2.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOBR
CDT
Founded
2004
2019
Country
United States
United States
Employees
N/A
4
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.4M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
SOBR
CDT
Price
$0.59
$2.92
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.3M
289.1K
Earning Date
04-10-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
103.55
N/A
EPS
N/A
N/A
Revenue
$437,421.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
105.62
N/A
52 Week Low
$0.35
$0.30
52 Week High
$4.39
$11.00

Technical Indicators

Market Signals
Indicator
SOBR
CDT
Relative Strength Index (RSI) 44.46 69.74
Support Level N/A $2.66
Resistance Level $0.94 $4.50
Average True Range (ATR) 0.33 0.21
MACD -0.04 0.35
Stochastic Oscillator 9.82 74.58

Price Performance

Historical Comparison
SOBR
CDT

About SOBR SOBR Safe Inc.

Sobr Safe Inc is a hardware and software company. The Company integrates proprietary software, SOBRsafeTM, with its patented touch-based personal alcohol awareness tracking products, SOBRcheckTM and SOBRsure, enabling non-invasive personal alcohol awareness tracking, biometric identity verification, and qualified, real-time cloud-based, informational alerts and reporting. It operates as a single segment designed to enable customers to purchase products directly through channel partners, sales agents or through its enterprise and consumer digital channels. Currently its principal markets are located in North America.

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.

Share on Social Networks: